Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Newly characterized species-specific immunogenic Chlamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies.

Marston EL, James AV, Parker JT, Hart JC, Brown TM, Messmer TO, Jue DL, Black CM, Carlone GM, Ades EW, Sampson J.

Clin Diagn Lab Immunol. 2002 Mar;9(2):446-52.

2.

Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin a.

Johnson SE, Dykes JK, Jue DL, Sampson JS, Carlone GM, Ades EW.

J Infect Dis. 2002 Feb 15;185(4):489-96. Epub 2002 Jan 31.

PMID:
11865401
3.

Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.

De BK, Sampson JS, Ades EW, Huebner RC, Jue DL, Johnson SE, Espina M, Stinson AR, Briles DE, Carlone GM.

Vaccine. 2000 Mar 6;18(17):1811-21.

PMID:
10699329
4.

Artificial NS4 mosaic antigen of hepatitis C virus.

Chang JC, Ruedinger B, Cong M, Lambert S, Lopareva E, Purdy M, Holloway BP, Jue DL, Ofenloch B, Fields HA, Khudyakov YE.

J Med Virol. 1999 Dec;59(4):437-50.

PMID:
10534724
5.

Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus.

Khudyakov YE, Lopareva EN, Jue DL, Crews TK, Thyagarajan SP, Fields HA.

J Clin Microbiol. 1999 Sep;37(9):2863-71.

6.

Antigenic epitopes of the hepatitis A virus polyprotein.

Khudyakov YE, Lopareva EN, Jue DL, Fang S, Spelbring J, Krawczynski K, Margolis HS, Fields HA.

Virology. 1999 Aug 1;260(2):260-72.

7.

Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides.

Chang JC, Seidel C, Ofenloch B, Jue DL, Fields HA, Khudyakov YE.

Virology. 1999 Apr 25;257(1):177-90.

8.

Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides.

da Fonseca DP, Joosten D, van der Zee R, Jue DL, Singh M, Vordermeier HM, Snippe H, Verheul AF.

Infect Immun. 1998 Jul;66(7):3190-7.

9.

Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.

Reed RC, Louis-Wileman V, Cosmai EV, Fang S, Jue DL, Wohlhueter RM, Hunter RL, Lal AA.

Vaccine. 1997 Apr;15(5):482-8.

PMID:
9160515
10.

Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.

Yang C, Collins WE, Xiao L, Saekhou AM, Reed RC, Nelson CO, Hunter RL, Jue DL, Fang S, Wohlhueter RM, Udhayakumar V, Lal AA.

Vaccine. 1997 Mar;15(4):377-86.

PMID:
9141208
11.

Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax.

Collins WE, Sullivan JS, Morris CL, Galland GG, Jue DL, Fang S, Wohlhueter R, Reed RC, Yang C, Hunter RL, Lal AA.

Am J Trop Med Hyg. 1997 Feb;56(2):200-10.

PMID:
9080881
12.

Rapid onset of malaria-induced mortality by immunizations with lipo-peptides: an experimental model to study deleterious immune responses and immunopathology in malaria.

Reed RC, Verhuel AF, Hunter RL, Udhayakumar V, Louis-Wileman V, Jennings VJ, Jue DL, Wohlhueter RM, Lal AA.

Vaccine. 1997 Jan;15(1):65-70.

PMID:
9041668
13.

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein.

Favorov MO, Khudyakov YE, Mast EE, Yashina TL, Shapiro CN, Khudyakova NS, Jue DL, Onischenko GG, Margolis HS, Fields HA.

J Med Virol. 1996 Sep;50(1):50-8.

PMID:
8890041
14.

Artificial mosaic proteins as new immunodiagnostic reagents: the hepatitis E virus experience.

Fields HA, Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BF, Lambert SB, Jue DL.

Clin Diagn Virol. 1996 May;5(2-3):167-79.

PMID:
15566875
15.

Monopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids.

Verheul AF, Udhayakumar V, Jue DL, Wohlhueter RM, Lal AA.

J Immunol Methods. 1995 Jun 9;182(2):219-26.

PMID:
7540640
16.

Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.

Khudyakov Yu E, Khudyakova NS, Jue DL, Lambert SB, Fang S, Fields HA.

Virology. 1995 Jan 10;206(1):666-72.

PMID:
7530398
17.

Artificial mosaic protein containing antigenic epitopes of hepatitis E virus.

Khudyakov YE, Favorov MO, Khudyakova NS, Cong ME, Holloway BP, Padhye N, Lambert SB, Jue DL, Fields HA.

J Virol. 1994 Nov;68(11):7067-74.

18.

Antigenic diversity in the circumsporozoite protein of Plasmodium falciparum abrogates cytotoxic-T-cell recognition.

Udhayakumar V, Shi YP, Kumar S, Jue DL, Wohlhueter RM, Lal AA.

Infect Immun. 1994 Apr;62(4):1410-3.

19.
20.

Immunodominant antigenic regions in a structural protein of the hepatitis E virus.

Khudyakov YuE, Favorov MO, Jue DL, Hine TK, Fields HA.

Virology. 1994 Jan;198(1):390-3.

PMID:
8259678
21.

Characterization of Hb Volga [beta 27(B9)Ala-->Asp] and Hb J-Wenchang-Wuming [alpha 11(A9)Lys-->Gln] in the population of the United States.

Wang WC, Carter H, Choitz HC, Hall R, Hine TK, Jue DL, Moo-Penn WF.

Hemoglobin. 1993 Feb;17(1):67-71. No abstract available.

PMID:
8454471
22.

Hb Rancho Mirage [beta 143(H21)His----Asp]; a variant in the 2,3-DPG binding site showing normal oxygen affinity at physiological pH.

Moo-Penn WF, Hine TK, Johnson MH, Jue DL, Holland S, George S, Pierce AM, Michalski LA, McDonald MJ.

Hemoglobin. 1992;16(1-2):35-44.

PMID:
1634360
23.

Erythrocytosis secondary to HB Bunbury [alpha 2 beta (2)94(FG1)Asp----Asn].

Ballas SK, Park D, Fernandez L, Hine TK, Jue DL, Johnson MH, Moo-Penn WF.

Hemoglobin. 1992;16(4):281-6. No abstract available.

PMID:
1517105
24.

Hb Luxembourg [alpha 24(B5)Tyr----His], Hb Maputo [beta 47(CD6)Asp----Tyr], and Hb Fukuyama [beta 77(EF1)His----Tyr].

Moo-Penn WF, Hine TK, Johnson MH, Jue DL, Piersma H, Therrell B Jr, Chu A.

Hemoglobin. 1991;15(1-2):97-101. No abstract available.

PMID:
1917540
25.

Hb St. Francis [beta 121(GH4)Glu----Gly]: a new mutation at the same site as Hb D-Los Angeles.

Abourzik NN, Conlon M, Zordon G, Hine TK, Johnson MH, Jue DL, Moo-Penn WF.

Hemoglobin. 1991;15(1-2):115-7. No abstract available.

PMID:
1917532
26.

Structural, functional, and subunit assembly properties of hemoglobin Attleboro [alpha 138 (H21) Ser----Pro], a variant possessing a site maturation at a critical C-terminal residue.

McDonald MJ, Michalski LA, Turci SM, Guillette RA, Jue DL, Johnson MH, Moo-Penn WF.

Biochemistry. 1990 Jan 9;29(1):173-8.

PMID:
2108715
27.

Hb Jacksonville [alpha 2 beta 2(54)(D5)Val----Asp]: a new unstable variant found in a patient with hemolytic anemia.

Gaudry CL Jr, Pitel PA, Jue DL, Hine TK, Johnson MH, Moo-Penn WF.

Hemoglobin. 1990;14(6):653-9. No abstract available.

PMID:
2101840
28.

Hb Catonsville (glutamic acid inserted between Pro-37(C2)alpha and Thr-38(C3)alpha). Nonallelic gene conversion in the globin system?

Moo-Penn WF, Swan DC, Hine TK, Baine RM, Jue DL, Benson JM, Johnson MH, Virshup DM, Zinkham WH.

J Biol Chem. 1989 Dec 25;264(36):21454-7.

29.
30.

Hemoglobin Brockton [beta 138 (H16) Ala----Pro]: an unstable variant near the C-terminus of the beta-subunits with normal oxygen-binding properties.

Moo-Penn WF, Jue DL, Johnson MH, Olsen KW, Shih D, Jones RT, Lux SE, Rodgers P, Arnone A.

Biochemistry. 1988 Oct 4;27(20):7614-9.

PMID:
3207692
31.

Hemoglobin Swan River [alpha 6(A4)Asp----Gly].

Moo-Penn WF, Jue DL, Johnson MH, Therrell BL.

Hemoglobin. 1987;11(1):61-2. No abstract available.

PMID:
3583768
32.

A case of hemoglobin Indianapolis [beta 112(G14) Cys----Arg] in an individual from Cordoba, Spain.

Baiget M, Gomez Pereira C, Jue DL, Johnson MH, McGuffey JE, Moo-Penn WF.

Hemoglobin. 1986;10(5):483-94.

PMID:
3781865
33.

Hemoglobin New Mexico: beta 100 (G2) Pro----Arg. A variant hemoglobin associated with erythrocytosis.

Moo-Penn WF, McGuffey JE, Jue DL, Johnson MH, Schum T.

Biochim Biophys Acta. 1985 Nov 29;832(2):192-6.

PMID:
3840697
34.

Separation of hemoglobin variants by ion-exchange chromatography on Monobead resins.

Moo-Penn WF, Jue DL.

J Chromatogr. 1985 Jan 18;318(2):325-32.

PMID:
3980625
35.

Hemoglobin Savaria--alpha 49(CE7)Ser----Arg in the United States.

Suarez CR, Jue DL, Moo-Penn WF.

Hemoglobin. 1985;9(6):627-9. No abstract available.

PMID:
3937825
36.

Hemoglobin Twin Peaks alpha 113 (GH1) Leu----His.

Guis M, Mentzer WC, Jue DL, Johnson MH, McGuffey JE, Moo-Pen WF.

Hemoglobin. 1985;9(2):175-7. No abstract available.

PMID:
3839772
37.

Structural and functional studies of hemoglobin Wayne: an elongated alpha-chain variant.

Moo-Penn WF, Jue DL, Johnson MH, McDonald MJ, Turci SM, Shih TB, Jones RT, Therrell BL Jr, Arnone A.

J Mol Biol. 1984 Dec 25;180(4):1119-40.

PMID:
6527384
38.
39.

Hemoglobin Evanston: alpha 14(A12) Trp leads to Arg. A variant hemoglobin associated with alpha-thalassemia-2.

Moo-Penn WF, Baine RM, Jue DL, Johnson MH, McGuffey JE, Benson JM.

Biochim Biophys Acta. 1983 Sep 14;747(1-2):65-70.

PMID:
6882779
40.

Hemoglobin Cheverly: an unstable hemoglobin associated with chronic mild anemia.

Yeager AM, Zinkham WH, Jue DL, Winslow RM, Johnson MH, McGuffey JE, Moo-Penn WF.

Pediatr Res. 1983 Jun;17(6):503-7.

PMID:
6877904
41.

Hemoglobin Rio Grande [beta 8 (A5) Lys leads to Thr] a new variant found in a Mexican-American family.

Moo-Penn WF, Johnson MH, McGuffey JE, Jue DL, Therrell BL Jr.

Hemoglobin. 1983;7(1):91-5. No abstract available.

PMID:
6857757
42.

Hemoglobin Queens: alpha 34 (B15) Leu-Arg structural and functional properties and its association with Hb E.

Moo-Penn WF, Jue DL, Johnson MH, McGuffey JE, Simpkins H, Katz J.

Am J Hematol. 1982 Dec;13(4):323-7.

PMID:
7158628
43.

Hemoglobin connecticut (beta 21 (B3) Asp leads to Gly): a hemoglobin variant with low oxygen affinity.

Moo-Penn WF, McPhedran P, Bobrow S, Johnson MH, Jue DL, Olsen KW.

Am J Hematol. 1981 Sep;11(2):137-45.

PMID:
7304605
44.
45.

Hemoglobin Tampa:beta 79 (EF3) aspartic acid replaced by tyrosine.

Johnson MH, Jue DL, Patchen LC, Hartwig EC Jr, Schneider NJ, Moo-Penn WF.

Biochim Biophys Acta. 1980 May 29;623(1):119-23.

PMID:
7378467
46.

Hemoglobin variants and methods used for their characterization during 7 years of screening at the Center for Disease Control.

Moo-Penn WF, Jue DL, Johnson MH, Bechtel KC, Patchen LC.

Hemoglobin. 1980;4(3-4):347-61.

PMID:
6252122
47.

Hemoglobin Dunn: alpha 6 (A4) aspartic acid replaced by asparagine.

Jue DL, Johnson MH, Patchen LC, Moo-Penn WF.

Hemoglobin. 1979;3(2-3):137-43.

PMID:
478975
48.

Hemoglobin Presbyterian: beta108 (G10) asparagine leads to lysine, A hemoglobin variant with low oxygen affinity.

Moo-Penn WF, Wolff JA, Simon G, Vacek M, Jue DL, Johnson MH.

FEBS Lett. 1978 Aug 1;92(1):53-6. No abstract available.

49.

Hemoglobin J Rovigo (alpha53 Ala replaced by Asp) in association with beta-thalassemia.

Moo-Penn WF, Jue DL, Baine RM.

Hemoglobin. 1978;2(5):443-5. No abstract available.

PMID:
31339
50.

Hemoglobin Raleigh (beta1 valine replaced by acetylalanine). Structural and functional characterization.

Moo-Penn WF, Bechtel KC, Schmidt RM, Johnson MH, Jue DL, Schmidt DE Jr, Dunlap WM, Opella SJ, Bonaventura J, Bonaventura C.

Biochemistry. 1977 Nov 1;16(22):4872-9. No abstract available.

PMID:
20942

Supplemental Content

Support Center